Profile
Michael Hamill is currently an Origination Partner at Flagship Pioneering, Inc. since 2025.
Formerly, Dr. Hamill was Vice President-Research at Axcella Health, Inc. from 2011 to 2021.
Dr. Hamill earned a doctorate from Boston University and completed undergraduate degrees at Gettysburg College.
Michael Hamill active positions
| Companies | Position | Start |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 2021-06-30 |
Former positions of Michael Hamill
| Companies | Position | End |
|---|---|---|
| AXCA HEALPAR | Corporate Officer/Principal | 2021-05-31 |
Training of Michael Hamill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Gettysburg College
Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
- Stock Market
- Insiders
- Michael Hamill
















